tiprankstipranks
Trending News
More News >
Nirvana Life Sciences Inc (TSE:NIRV)
:NIRV
Canadian Market
Advertisement

Nirvana Life Sciences Inc (NIRV) Income Statement

Compare
6 Followers

Nirvana Life Sciences Inc Income Statement

Last quarter (Q3 2023), Nirvana Life Sciences Inc's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Nirvana Life Sciences Inc's net income was C$5.37K. See Nirvana Life Sciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 23Jun 22Dec 20Dec 19Dec 18
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
-C$ 1.18MC$ 314.24KC$ 74.83KC$ 159.69K
Depreciation and Amortization
C$ 91.64KC$ 91.64K-C$ 171.86KC$ 161.14K
EBITDA
-C$ 3.40MC$ -314.24KC$ -74.53KC$ -159.69K
Operating Income
-C$ -859.12KC$ -314.24KC$ -74.53KC$ -159.69K
Other Income/Expenses
-C$ -4.49M-C$ 91.09KC$ 33.76K
Pretax Income
-C$ -5.66MC$ -314.24KC$ 13.31KC$ -129.25K
Net Income
-C$ -5.65MC$ -314.24KC$ 13.31KC$ -129.25K
Per Share Metrics
Basic EPS
C$ 0.00C$ -0.15C$ -0.01C$ 0.00C$ 0.00
Diluted EPS
C$ 0.00C$ -0.15C$ -0.01C$ 0.00C$ 0.00
Weighted Average Shares Outstanding
17.04M 36.52M 33.02M 33.02M 33.02M
Weighted Average Shares Outstanding (Diluted)
17.04M 36.52M 33.02M 33.02M 33.02M
Currency in CAD

Nirvana Life Sciences Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis